Assenagon Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.8M | Buy |
867,939
+155,358
| +22% | +$2.66M | 0.02% | 379 |
|
|
2025
Q1 | $45.5M | Buy |
712,581
+580,123
| +438% | +$37M | 0.08% | 209 |
|
|
2024
Q4 | $16.1M | Sell |
132,458
-217,594
| -62% | -$26.5M | 0.03% | 374 |
|
|
2024
Q3 | $43.7M | Sell |
350,052
-9,644
| -3% | -$1.2M | 0.08% | 184 |
|
|
2024
Q2 | $56.8M | Sell |
359,696
-77,994
| -18% | -$12.3M | 0.13% | 112 |
|
|
2024
Q1 | $56.7M | Buy |
437,690
+53,911
| +14% | +$6.98M | 0.13% | 104 |
|
|
2023
Q4 | $37M | Sell |
383,779
-44,554
| -10% | -$4.3M | 0.1% | 146 |
|
|
2023
Q3 | $51.9M | Sell |
428,333
-297,454
| -41% | -$36.1M | 0.16% | 98 |
|
|
2023
Q2 | $83.1M | Buy |
725,787
+116,639
| +19% | +$13.4M | 0.29% | 49 |
|
|
2023
Q1 | $84M | Sell |
609,148
-123,384
| -17% | -$17M | 0.3% | 56 |
|
|
2022
Q4 | $94.9M | Sell |
732,532
-396,484
| -35% | -$51.4M | 0.34% | 51 |
|
|
2022
Q3 | $125M | Buy |
1,129,016
+685,845
| +155% | +$75.8M | 0.48% | 36 |
|
|
2022
Q2 | $33.2M | Sell |
443,171
-107,849
| -20% | -$8.08M | 0.12% | 145 |
|
|
2022
Q1 | $43M | Buy |
551,020
+332,503
| +152% | +$26M | 0.12% | 128 |
|
|
2021
Q4 | $19.7M | Buy |
218,517
+214,664
| +5,571% | +$19.3M | 0.06% | 185 |
|
|
2021
Q3 | $356K | Buy |
+3,853
| New | +$356K | ﹤0.01% | 1083 |
|
|
2020
Q4 | – | Sell |
-66,590
| Closed | -$9.35M | – | 1199 |
|
|
2020
Q3 | $9.35M | Buy |
+66,590
| New | +$9.35M | 0.05% | 175 |
|
|
2020
Q1 | – | Sell |
-6,663
| Closed | -$860K | – | 933 |
|
|
2019
Q4 | $860K | Buy |
+6,663
| New | +$860K | 0.01% | 552 |
|
|
2019
Q1 | – | Sell |
-15,522
| Closed | -$1.69M | – | 1064 |
|
|
2018
Q4 | $1.69M | Buy |
+15,522
| New | +$1.69M | 0.02% | 460 |
|